Author

Daniel R Sill

Observed name: Daniel R. Sill

Institution: Mayo Clinic

Observed institution: Mayo Clinic

OpenAlex ID: A5025327740

Evaluation of 3,606 renal cell tumors for TFE3 rearrangements and TFEB alterations via fluorescence in situ hybridization, next generation sequencing, and GPNMB immunohistochemistry

2025 · Rumeal D. Whaley, Daniel R. Sill, et al. · Human Pathology · 28

HER2 Testing for Breast Cancer in the Genomics Laboratory: A Sea Change for Fluorescence In Situ Hybridization

2020 · Katherine B. Geiersbach, Daniel R. Sill, et al. · Archives of Pathology & Laboratory Medicine · 6

Evaluation of Atypical Fluorescence in Situ Hybridization Findings by RNA Sequencing

2025 · Beth A. Pitel, Saba Alvand, et al. · Journal of Molecular Diagnostics · 2

Cytogenetic and pathologic characterization of MYC-rearranged B-cell lymphomas in pediatric and young adult patients

2024 · Marie-France Gagnon, Frido K. Bruehl, et al. · Journal of Hematopathology · 2

Detailed Reanalysis of 500 Breast Cancers With Equivocal HER2 Immunohistochemistry and Borderline ERBB2 Fluorescence In Situ Hybridization Results

2021 · Katherine B Geiersbach, Daniel R Sill, et al. · American Journal of Clinical Pathology · 1

Working Up Group 4 Equivocal HER2 Samples Tested by Fluorescence in Situ Hybridization in a Reference Laboratory Setting: Past, Present, and Future

2019 · Katherine B. Geiersbach, Reid G. Meyer, et al. · Journal of Clinical Oncology · 1

EWSR1-rearranged renal neoplasia: Clinicopathologic and molecular characterization of 39 cases from a single institution

2026 · Robert G. Colef, Ganesh P. Pujari, et al. · Human Pathology

Fluorescence in situ hybridization (FISH)-based detection of paracentric inversions leading to RBM10::TFE3 rearrangement

2025 · Sounak Gupta, Daniel R. Sill, et al. · Human Pathology

Works count: 8

Citation count: 40

H-index: 2

I10-index: 1